Table 3.
(A) Multivariate analyses of grade 2 or higher late gastrointestinal toxicity. (B) Multivariate analyses of grade 2 or higher late genitourinary toxicity
Variable | n | HR | 95% CI | P | |
---|---|---|---|---|---|
(A) | |||||
Patient age | ≤64 | 418 | 1.000 | (ref) | — |
65–69 | 352 | 2.209 | 0.886–5.507 | 0.089 | |
70–74 | 359 | 2.996 | 1.252–7.168 | 0.014 | |
≥75 | 246 | 3.147 | 1.241–7.981 | 0.016 | |
Total ADT (month) | ≥6 | 699 | 0.941 | 0.544–1.626 | 0.826 |
Anticoagulant drugs | Yes | 142 | 1.676 | 0.839–3.347 | 0.143 |
Diabetes mellitus | Yes | 145 | 2.289 | 1.203–4.355 | 0.012 |
(B) | |||||
Patient age | ≤64 | 418 | 1.000 | (ref) | — |
65–69 | 352 | 1.224 | 0.325–4.608 | 0.766 | |
70–74 | 359 | 1.698 | 0.491–5.872 | 0.403 | |
≥75 | 246 | 5.055 | 1.626–15.714 | 0.005 | |
Total ADT (month) | ≥6 | 699 | 1.466 | 0.678–3.168 | 0.331 |
Anticoagulant drugs | Yes | 142 | 1.942 | 0.833–4.529 | 0.125 |
Diabetes mellitus | Yes | 145 | 1.707 | 0.700–4.162 | 0.240 |
ADT, androgen deprivation therapy.